Published in Platelets on February 01, 2001
Comparison of Two Different Blood Sample Tubes for Platelet Function Analysis with the Multiplate® System. Transfus Med Hemother (2010) 0.80
Investigations of Platelet Function in Whole Blood with BAPA as Anticoagulant. Transfus Med Hemother (2010) 0.79
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
The present role of coronary artery surgery. Practitioner (1982) 3.08
The 5' nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro. J Virol (1991) 2.83
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg (1990) 2.07
Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol (1994) 2.00
Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial. Heart (2001) 1.93
Detection of hepatitis A virus in environmental samples by antigen-capture PCR. Appl Environ Microbiol (1994) 1.87
Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg (2000) 1.75
Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg (1993) 1.66
Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis (1993) 1.62
A new porcine bioprosthesis: in vitro and in vivo evaluation. Life Support Syst (1985) 1.55
In vitro calcification of bioprosthetic heart valves: report of a novel method and review of the biochemical factors involved. J Heart Valve Dis (1992) 1.45
Plasma albumin and haemodilution: the problem of interpretation in sequential studies. Ann Clin Biochem (1989) 1.42
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Respiratory dysfunction following cardiopulmonary bypass: verification of a non-invasive technique to measure shunt fraction. Respir Med (1993) 1.38
Endocarditis as a manifestation of Chlamydia B infection (psittacosis). Br Heart J (1977) 1.24
Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. Infect Immun (1995) 1.13
A real time 2-dimensional ultrasonic scanner for clinical use. Ultrasonics (1976) 1.04
Two-dimensional echocardiography with a wide angle (60 degrees) sector scanner. Br Heart J (1977) 1.01
Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters. Infect Immun (1992) 1.00
The management of ventricular septal rupture following myocardial infarction. Q J Med (1980) 0.99
Differentiation between gaseous and formed embolic materials in vivo. Application in prosthetic heart valve patients. Stroke (1994) 0.97
Analysis of hepatitis A virus translation in a T7 polymerase-expressing cell line. Arch Virol Suppl (1994) 0.94
Coronary artery disease patients' perception of their health and expectations of benefit following coronary artery bypass grafting. J Adv Nurs (2000) 0.92
A prospective evaluation of the Björk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses. Circulation (1986) 0.92
Assessment of changes in general health status using the short-form 36 questionnaire 1 year following coronary artery bypass grafting. Eur J Cardiothorac Surg (2000) 0.92
The influence of general health status and social support on symptomatic outcome following coronary artery bypass grafting. Heart (2001) 0.91
Sudden coronary death in Glasgow: nature and frequency of acute coronary lesions. Br Heart J (1987) 0.91
In vitro blood compatibility of surface-modified polyurethanes. Biomaterials (1998) 0.91
Arrhythmia prophylaxis after coronary artery surgery. A randomised controlled trial of intravenous magnesium chloride. Eur J Cardiothorac Surg (1993) 0.88
Dynamic modelling of prosthetic chorded mitral valves using the immersed boundary method. J Biomech (2006) 0.87
Transcranial Doppler detection of microemboli in prosthetic heart valve patients: dependency upon valve type. Eur J Cardiothorac Surg (1996) 0.87
A new design for polyurethane heart valves. J Heart Valve Dis (2001) 0.87
New polyurethane heart valve prosthesis: design, manufacture and evaluation. Biomaterials (1996) 0.87
Confocal laser scanning microscopy of calcified bioprosthetic heart valves. J Heart Valve Dis (1994) 0.86
Calcification and stress distribution in bovine pericardial heart valves. J Biomed Mater Res (1992) 0.86
Prostacyclin in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg (1982) 0.86
Primary tissue failure in pericardial heart valves. J Thorac Cardiovasc Surg (1987) 0.85
Non-invasive assessment by Doppler ultrasound of 155 patients with bioprosthetic valves: a comparison of the Wessex porcine, low profile Ionescu-Shiley, and Hancock pericardial bioprostheses. Br Heart J (1986) 0.85
On the origin of cerebrovascular microemboli associated with prosthetic heart valves. Neurol Res (1995) 0.84
A double blind study of prostacyclin in cardiopulmonary bypass surgery. Br J Haematol (1981) 0.84
Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass. Thromb Res (2000) 0.84
Role of genotypic analysis of the thymidine kinase gene of herpes simplex virus for determination of neurovirulence and resistance to acyclovir. J Clin Microbiol (1999) 0.83
Myocardial infarction related to coronary artery bypass graft surgery. Br Heart J (1984) 0.83
Detection of microemboli by transcranial Doppler ultrasound. Tex Heart Inst J (1996) 0.83
Immediate effects of pericardiectomy. J Thorac Cardiovasc Surg (1973) 0.83
Platelet aggregation and high-intensity transient signals (HITS) in a sheep model of mitral valve replacement. J Heart Valve Dis (1999) 0.82
Porcine versus pericardial bioprostheses: eleven-year follow up of a prospective randomized trial. J Heart Valve Dis (2000) 0.82
Examination of fixative penetration in glutaraldehyde-treated bovine pericardium by stratigraphic analysis of shrinkage temperature measurements using differential scanning calorimetry. Life Support Syst (1988) 0.81
Ventilatory and gas exchange abnormalities on exercise in chronic heart failure. Eur Respir J (1995) 0.81
The time course of pulmonary transfer factor changes following heart transplantation. Eur J Cardiothorac Surg (1997) 0.81
Effects of cardiac surgery and intraoperative hypothermia on energy expenditure as measured by doubly labelled water. Br J Surg (1991) 0.80
In vitro evaluation of six mechanical and six bioprosthetic valves. Thorac Cardiovasc Surg (1986) 0.80
Calcification and fatigue failure in a polyurethane heart value. Biomaterials (1995) 0.80
Tissue culture, protein and collagen synthesis in antibiotic sterilized canine heart valves. Cardiovasc Res (1976) 0.80
Reconstruction of right ventricular outflow with a valved homograft conduit. Thorax (1974) 0.79
Hypotensive and sedative properties of alpha-adrenoceptor agonists: relation to pre- and post-synaptic stimulation [proceedings]. Br J Pharmacol (1980) 0.79
Diethylcarbamazine-related antimicrobial activity in Mycobacterium tuberculosis-infected blood. J Antimicrob Chemother (1998) 0.79
Exercise intolerance following heart transplantation: the role of pulmonary diffusing capacity impairment. Chest (2000) 0.79
Dynamic in vitro calcification of porcine aortic valves. J Heart Valve Dis (1994) 0.79
Polyurethane heart valves: fatigue failure, calcification, and polyurethane structure. J Biomed Mater Res (1997) 0.79
Biocompatibility of cardiopulmonary bypass: influence on blood compatibility of device type, mode of blood flow and duration of application. Int J Artif Organs (1994) 0.79
Genetic variability within the 5' nontranslated region of hepatitis A virus RNA. Implications for secondary structure and function. J Hepatol (1991) 0.78
Chemical modification of bovine pericardium and its effect on calcification in the rat subdermal model. Biomaterials (1992) 0.78
The measurement of the single-breath transfer factor for carbon monoxide and its components using the Morgan Transflow system. Respir Med (1998) 0.78
Transcranial Doppler ultrasound signals associated with prosthetic heart valves: an in vitro study. J Heart Valve Dis (1995) 0.78
Mechanisms of pulmonary transfer factor decline following heart transplantation. Eur J Cardiothorac Surg (2000) 0.78
Animal evaluation of a new pericardial bioprosthetic heart valve. Artif Organs (1988) 0.78
Monitoring of factor XII activity and granulocyte elastase release during cardiopulmonary bypass. ASAIO Trans (1992) 0.78
Post implantation viability in canine allograft heart valves. Cardiovasc Res (1977) 0.78
Endotoxemia, complement, and white blood cell activation in cardiac surgery: a randomized trial of laxatives and pulsatile perfusion. Ann Thorac Surg (1994) 0.78
Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol (1996) 0.78
Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators. Eur J Cardiothorac Surg (1996) 0.77
Severe haemolysis with the St. Jude Medical prosthesis. Eur J Cardiothorac Surg (1988) 0.77
In vitro function and durability assessment of a novel polyurethane heart valve prosthesis. Artif Organs (1996) 0.77
Nucleotide sequences important in DNA replication are responsible for differences in the capacity of two herpes simplex virus strains to spread from cornea to central nervous system. Curr Eye Res (1987) 0.77
Coronary artery bypass surgery--impact upon a patient's wife--a pilot study. Thorac Cardiovasc Surg (1984) 0.77
Protecting the damaged heart during coronary surgery. Heart (2003) 0.77
Detection of cytomegalovirus in upper gastrointestinal biopsies from heart transplant recipients: comparison of light microscopy, immunocytochemistry, in situ hybridisation, and nested PCR. J Clin Pathol (1998) 0.77
Quantitative detection of platelet aggregates in whole blood without fixation. Platelets (2000) 0.77
Viability in human heart valves prepared for grafting. Cardiovasc Res (1976) 0.77
Enterotoxigenic Escherichia coli detected in foods by PCR and an enzyme-linked oligonucleotide probe. Int J Food Microbiol (1996) 0.77
Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage. Atherosclerosis (2003) 0.76
The effects of left atrial and left ventricular cannulation on left ventricular function. Int J Artif Organs (1985) 0.76
Alterations in renal microcirculation during cardiopulmonary bypass. Ann Thorac Surg (1998) 0.76
Polyurethane heart valve durability: effects of leaflet thickness and material. Int J Artif Organs (1997) 0.76
Heparin and platelet function. Ann Thorac Surg (2001) 0.75
Preoperative platelet inhibition and bleeding after cardiopulmonary bypass. J Thorac Cardiovasc Surg (2003) 0.75
In response to: Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies. J Heart Valve Dis (1993) 0.75
Platelet transfusion and bleeding after cardiopulmonary bypass. Jpn Heart J (2002) 0.75
Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible? Eur J Cardiothorac Surg (2001) 0.75
Heparin and time-dependent platelet dysfunction during cardiac surgery. Blood Coagul Fibrinolysis (2002) 0.75
A retrocardiac shadow in an immunocompromised patient. Postgrad Med J (1997) 0.75